Regeneron Pharmaceuticals (REGN) News Today $614.79 +18.25 (+3.06%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock REGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Teza Capital Management LLCTeza Capital Management LLC increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 49.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,294 shares of the biopharmMay 21 at 6:25 AM | marketbeat.comQuantinno Capital Management LP Sells 2,442 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Quantinno Capital Management LP decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 32.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,031 shares of the biopharmaceutical company'May 21 at 5:19 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $890.60 Average Price Target from AnalystsMay 21 at 2:47 AM | americanbankingnews.comRegeneron to acquire 23andMe DNA testing firm. How that could impact your genetic dataMay 21 at 2:26 AM | msn.comNow we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.May 20 at 8:45 PM | msn.com23andMe, including sensitive genetic data, sold to biotech company Regeneron PharmaceuticalsMay 20 at 7:33 PM | finance.yahoo.comRegeneron Pharmaceuticals, Inc. (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)May 20 at 4:16 PM | seekingalpha.com588 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Strive Asset Management LLCStrive Asset Management LLC bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 588 shares oMay 20 at 6:45 AM | marketbeat.com2,000 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Tang Capital Management LLCTang Capital Management LLC acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,000 shares of the biopharmaceutical companyMay 20 at 6:24 AM | marketbeat.com5,849 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Tema Etfs LLCTema Etfs LLC bought a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 5,849 shares of the biopharmaceutical company's stock, valMay 20 at 6:16 AM | marketbeat.comToronto Dominion Bank Acquires 5,286 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Toronto Dominion Bank lifted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 9.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 60,005 shares of the biopharmaceutical company's stock after purMay 20 at 6:15 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Royal Bank of CanadaRoyal Bank of Canada increased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 10.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 288,937 shares of the biopharmaceutical company's sMay 20 at 5:39 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Cut by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 96.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 847 shares of the biopharmaceutical company's stock after selling 22,744 shareMay 20 at 4:38 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twenty-six ratings firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issMay 20 at 2:19 AM | marketbeat.comRegeneron Buys 23andMe in Bankruptcy AuctionMay 19 at 1:05 PM | investopedia.comRegeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millionsMay 19 at 12:39 PM | nypost.comPharma giant Regeneron to buy 23andMe and its customers' data for $256MMay 19 at 10:35 AM | techcrunch.comRegeneron Pharmaceuticals to buy 23andMe and its data for $256 millionMay 19 at 10:14 AM | cnbc.com23andMe, Inc.: Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised SaleMay 19 at 10:13 AM | finanznachrichten.de23andMe Sells Gene-Testing Business to DNA Drug Maker RegeneronMay 19 at 10:13 AM | msn.comRegeneron stock rises on 23andMe assets acquisitionMay 19 at 10:13 AM | in.investing.comRegeneron Pharmaceuticals to Acquire 23andMe for $256MMay 19 at 10:13 AM | msn.comRegeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA dataMay 19 at 10:13 AM | msn.comRegeneron to buy 23andMe out of bankruptcy for $256mMay 19 at 9:52 AM | proactiveinvestors.comRegeneron to Buy 23andMe Out of Bankruptcy for $256 MillionMay 19 at 7:48 AM | wsj.comRegeneron Pharmaceuticals Announces Successful Bid for 23andMe Assets in $256 Million AcquisitionMay 19 at 7:45 AM | quiverquant.comRegeneron to buy bankrupt genetic testing firm 23andMe for $256 millionMay 19 at 7:43 AM | reuters.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is Scientech Research LLC's 4th Largest PositionScientech Research LLC raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 193.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,622 shares of tMay 19 at 7:17 AM | marketbeat.comRegeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and WellnessMay 19 at 7:07 AM | globenewswire.comPathstone Holdings LLC Sells 1,254 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Pathstone Holdings LLC lowered its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 8.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 13,677 shares of the biopharmaceutical company's stock after selling 1,254 shares durMay 19 at 5:27 AM | marketbeat.comJanus Henderson Group PLC Sells 84,661 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Janus Henderson Group PLC lessened its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 86.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,473 shares of the biopharmaceutical company's stock afteMay 19 at 4:34 AM | marketbeat.comSherbrooke Park Advisers LLC Buys New Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Sherbrooke Park Advisers LLC purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,004 shares of the biopharmaceuMay 18 at 7:45 AM | marketbeat.comSig Brokerage LP Purchases Shares of 1,064 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Sig Brokerage LP acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,064 shares of the biopharmaceutical company's stock, valued at aMay 18 at 7:28 AM | marketbeat.comRaiffeisen Bank International AG Acquires New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Raiffeisen Bank International AG acquired a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,May 18 at 6:35 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by ProShare Advisors LLCProShare Advisors LLC raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 21.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 146,135 shares of the biopharmaceutical cMay 18 at 5:57 AM | marketbeat.comMan Group plc Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Man Group plc decreased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 40.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 36,144 shares of the biopharmaceutical company's stock after selling 24,377 shareMay 18 at 5:28 AM | marketbeat.comPolar Capital Holdings Plc Cuts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Polar Capital Holdings Plc lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 21.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,249 shares of the biopharmaMay 17, 2025 | marketbeat.com1,554 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Mufg Securities Americas Inc.Mufg Securities Americas Inc. bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,554 shares of the bioMay 17, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Nissay Asset Management Corp Japan ADVNissay Asset Management Corp Japan ADV grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,125 shaMay 17, 2025 | marketbeat.comNuveen Asset Management LLC Sells 211,009 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Nuveen Asset Management LLC trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 30.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 475,630 shares of the biopharmaceutical company's stock after selling 211,009 shMay 17, 2025 | marketbeat.comRegeneron Pharmaceuticals Inc (REGN) Celebrates Young Innovators at 75th Regeneron ISEF | REGN ...May 16, 2025 | gurufocus.com75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 CompetitionMay 16, 2025 | globenewswire.comRegeneron Pharmaceuticals (NASDAQ:REGN) Raised to Buy at CitigroupCitigroup upgraded Regeneron Pharmaceuticals from a "neutral" rating to a "buy" rating and upped their price objective for the company from $600.00 to $700.00 in a research note on Wednesday.May 16, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by OMERS ADMINISTRATION CorpOMERS ADMINISTRATION Corp lessened its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 23.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,979 shares ofMay 16, 2025 | marketbeat.comLazard Asset Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Lazard Asset Management LLC boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 22.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,912 shares of the biopharmaceutical companyMay 16, 2025 | marketbeat.comLighthouse Investment Partners LLC Purchases New Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Lighthouse Investment Partners LLC purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,300 shares of the biopMay 16, 2025 | marketbeat.comGraham Capital Management L.P. Makes New $1.07 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Graham Capital Management L.P. acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,506 shares of the biopMay 16, 2025 | marketbeat.comFocus Partners Wealth Buys 6,213 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Focus Partners Wealth lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 209.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,184 shares of the biopharmaceutical comMay 16, 2025 | marketbeat.comRegeneron Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:REGN | BenzingaMay 15, 2025 | benzinga.comCitigroup Upgrades Regeneron Pharmaceuticals (REGN)May 15, 2025 | msn.com Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼1.070.65▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼5929▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Exelixis News Neurocrine Biosciences News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
